PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Scripps scientists develop test providing new pathway for identifying obesity, diabetes drugs

2010-09-16
(Press-News.org) La Jolla, CA, September 15, 2010 – Scientists at The Scripps Research Institute have designed a new molecular test that will allow researchers to look for potential drugs targeting a human metabolic enzyme believed to stimulate the appetite and play a role in diabetes.

The new test, which the scientists call a simple assay, will allow researchers to look through hundreds of thousands of compounds for those that have potential to block the action of an enzyme known as ghrelin O-acyltransferase (GOAT). If drugs can be found that safely suppress the action of GOAT, they may help people who have clinical problems with appetite, obesity, and diabetes.

"There hasn't been a simple screen until now," says Kim D. Janda, Ph.D., a professor in the Departments of Chemistry and Immunology and Microbial Science, member of The Skaggs Institute for Chemical Biology, and director of The Worm Institute for Research and Medicine at Scripps Research.

Janda and Amanda Garner, Ph.D., a research associate in his laboratory, describe the new approach—which may also¬ prove useful for investigating other enzymes involved in a variety of diseases—in an advance, online Early edition of the journal Angewandte Chemie on September 15, 2010.

A Tempting Target

Even though GOAT was only discovered recently, in 2008, scientists had speculated for years that it had to exist. After all, its target (ghrelin, or the "G" in the acronym GOAT) had been known for more than a decade.

Ghrelin, a small peptide hormone that is mainly produced in the stomach, signals hunger, typically before meals. Ghrelin has been associated with Prader-Willi syndrome a common genetic cause of childhood obesity in which patients have exceptionally high ghrelin levels.

The biology of ghrelin is quite intricate. For ghrelin to impact the body's metabolism, it must move from the stomach to the brain, where it acts on neurons. GOAT acts as a "passport" check point station for the processing of 'pro-ghrelin.'

"Without GOAT's modification of 'pro-ghrelin,' ghrelin's entry into the brain, and thus its medicinal implications, are nullified," said Janda. "That's why GOAT has been coveted as a promising therapeutic target for obesity and diabetes."

However, the task of finding drug-like compounds that target GOAT has been complicated by the fact that the enzyme is difficult to work with. As a membrane-bound protein, GOAT cannot easily be purified to homogeneity and has to be suspended in a fatty environment.

Most critically, however, no user-friendly high-throughput screening tests had been developed for this class of enzymes. Current assay technology for targets similar to GOAT rely on radiolabeling techniques, which are labor-intensive and require additional safety precautions.

When Janda and Garner set out to develop an assay to monitor GOAT's activity, they aimed to change this situation.

Taking a Fresh Approach

The scientists were particularly interested in designing a fluorescence-based assay for GOAT. In contrast to radiolabeling techniques, fluorescence assays are safe, can easily be performed in a high-throughput format, and require only a simple light source.

In developing their new approach, the team was inspired by enzyme immunoassay strategies commonly used in biology, chemistry, and medicine, and by "click chemistry," a concept developed at Scripps Research. Because the amount of ghrelin modified by GOAT is minute, the scientists also used the principle of multi-turnover signal amplification for accurate detection.

In the end, the team succeeded in designing and creating the new technology—which they call "catalytic assay using enzyme-linked click chemistry assay" (cat-ELCCA).

"This new assay technology is both highly sensitive and reproducible," noted Janda, "making it an excellent assay for high-throughput screening."

Janda and Garner are now further developing the assay so that researchers can screen thousands to millions of compounds at once against the activity of GOAT.

INFORMATION: Work for the Angewandte Chemie article, "cat-ELCCA: A Robust Method to Monitor the Fatty Acid Acyltransferase Activity of Ghrelin O-Acyltransferase (GOAT)," was funded by the Skaggs Institute for Chemical Biology, and supported by a postdoctoral fellowship from the National Institutes of Health. For an abstract of the paper, see http://onlinelibrary.wiley.com/doi/10.1002/anie.201003387/abstract

About The Scripps Research Institute

The Scripps Research Institute is one of the world's largest independent, non-profit biomedical research organizations, at the forefront of basic biomedical science that seeks to comprehend the most fundamental processes of life. Scripps Research is internationally recognized for its discoveries in immunology, molecular and cellular biology, chemistry, neurosciences, autoimmune, cardiovascular, and infectious diseases, and synthetic vaccine development. An institution that evolved from the Scripps Metabolic Clinic founded by philanthropist Ellen Browning Scripps in 1924, Scripps Research currently employs approximately 3,000 scientists, postdoctoral fellows, scientific and other technicians, doctoral degree graduate students, and administrative and technical support personnel. Headquartered in La Jolla, California, the institute also includes Scripps Florida, whose researchers focus on basic biomedical science, drug discovery, and technology development. Scripps Florida is located in Jupiter, Florida. For more information, see www.scripps.edu



ELSE PRESS RELEASES FROM THIS DATE:

Fat stem cells safe for breast reconstruction when cancer is dormant, says Pitt team

2010-09-16
PITTSBURGH, Sept. 15 – Fat-derived stem cells can be safely used to aid reconstruction of breast tissue after mastectomy as long as there is no evidence of active cancer, according to researchers at the University of Pittsburgh School of Medicine. Their findings are available in Tissue Engineering Part A. Plastic surgeons have long moved fat from one part of the body into the breasts for reconstruction, but with some complications and a varying success rate, explained senior author Vera S. Donnenberg, Ph.D., assistant professor of surgery, Pitt School of Medicine. More ...

Significant weight-loss from surgery decreases risk for cardiovascular disease in women

2010-09-16
Significant weight loss not only improves daily life of morbidly obese woman but also decreases the risk for cardiovascular disease (CVD). However, many people can not lose weight or can not maintain weight loss without help. Bariatric surgery is emerging as a valuable procedure to help morbidly obese individuals lose weight, as studies have shown; it can improve many health profiles and lower mortality. Now, researchers have found another positive impact of significant weight loss after bariatric surgery: it can significantly improve the lipoprotein profiles of women within ...

NASA eyes Karl, now a hurricane in the Gulf of Mexico

NASA eyes Karl, now a hurricane in the Gulf of Mexico
2010-09-16
NASA's Aqua and TRMM satellites have been watching Karl's clouds and rainfall as he moved across Mexico's Yucatan Peninsula and into the Gulf of Mexico today, powering up into a hurricane. Infrared imagery of Karl's cloud temperatures from NASA's Atmospheric Infrared Sounder (AIRS) instrument this morning, Sept. 16 at 0753 UTC (3:53 a.m. EDT) showed strong convective activity in his center as indicated by high thunderstorms that were as cold as -63 Fahrenheit. That strong convection was an indication that the warm waters of the Gulf of Mexico were strengthening the storm. ...

Developing countries may not benefit from adopting international treaties

2010-09-16
CORVALLIS, Ore. – A new study by an Oregon State University business professor has found that developing countries that adopt major international economic treaties do not necessarily gain more foreign direct investment. In fact, in some cases adopting these treaties can hurt, not help a developing country, contrary to what agencies such as the World Trade Organization (WTO) espouse. The study, published in the current online version of the Journal of World Business, has major implications for Latin American and Caribbean intellectual policy reform Ted Khoury, an assistant ...

GOES-13 sees a weaker Hurricane Julia in the 'tropical trio'

GOES-13 sees a weaker Hurricane Julia in the tropical trio
2010-09-16
GOES-13 satellite imagery this morning showed the "tropical trio": Tropical Storm Karl over the Gulf of Mexico, Hurricane Igor in the central Atlantic, and a waning Hurricane Julia in the eastern Atlantic Ocean. Hurricane Julia has now lost her Category 4 Hurricane status, and is currently a Category 2 hurricane in the eastern Atlantic and weakening. Wind shear, cooler sea surface temperatures and warmer cloud top temperatures all spell a weaker Julia. The Geostationary Operational Environmental Satellite known as GOES-13 that monitors weather over the U.S. East Coast ...

Study: How Palestinian and Israeli children are psychologically scarred by exposure to war

2010-09-16
ANN ARBOR, Mich.---As another round of talks continues between Israelis and Palestinians, a new University of Michigan study documents the impact the violence has been inflicting on the region's children. Palestinian and Israeli children not only suffer the direct physical consequences of violence, they are also being psychologically scarred by the high levels of violence they witness, according to the study, presented earlier this summer at the International Society for Research on Aggression. Nearly 50 percent of Palestinian children between the ages of 11 and 14 ...

NASA'S LRO exposes moon's complex, turbulent youth

NASAS LRO exposes moons complex, turbulent youth
2010-09-16
The moon was bombarded by two distinct populations of asteroids or comets in its youth, and its surface is more complex than previously thought, according to new results from NASA's Lunar Reconnaissance Orbiter (LRO) spacecraft featured in three papers appearing in the Sept. 17 issue of Science. In the first paper, lead author James Head of Brown University in Providence, R.I., describes results obtained from a detailed global topographic map of the moon created using LRO's Lunar Orbiter Laser Altimeter (LOLA). "Our new LRO LOLA dataset shows that the older highland impactor ...

Pristine rainforests are 'biogeochemical reactors'

2010-09-16
A multinational team that includes a North Carolina State University researcher has found another piece of the atmospheric puzzle surrounding the effects of aerosol particles on climate change. Their findings will contribute to our ability to more accurately measure human impact on climate, and to determine how much pollution may "mask" the actual rate of climate change. Dr. Markus Petters, an NC State assistant professor of marine, earth and atmospheric sciences, traveled to the Amazon rainforest in a remote area of Brazil as part of a team that wanted to study how a ...

Fast-track gene-ID method speeds rare disease search

2010-09-16
ANN ARBOR, Mich. — A University of Michigan-led research team has identified a gene responsible in some families for a devastating inherited kidney disorder, thanks to a new, faster method of genetic analysis not available even two years ago. The success offers hope that scientists can speed the painstaking search for the genes responsible for many rare diseases and test drugs to treat them. The U-M scientists report their success with exome capture, a groundbreaking genetic analysis technique, in the September issue of Nature Genetics. The U-M- led international ...

A scientific breakthrough could be the first step in a better treatment for leukemia patients

2010-09-16
A discovery made by Dr. Tarik Möröy, President and Scientific Director and Director of the Hematopoiesis and Cancer research unit at the Institut de recherches cliniques de Montréal (IRCM), and his team was recently published in Blood, the official journal of the American Society of Hematology. The researchers found that a protein can regulate certain characteristics of blood stem cells, which could lead to a better treatment for leukemia patients. Dr. Cyrus Khandanpour, medical doctor and postdoctoral fellow in Dr. Möröy's laboratory, is the study's first author. The ...

LAST 30 PRESS RELEASES:

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

When getting a job makes you go hungry

Good vibrations could revolutionize assisted reproductive technology

[Press-News.org] Scripps scientists develop test providing new pathway for identifying obesity, diabetes drugs